Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C

OBJECTIVES: Combination therapy with pegylated interferon (Peg) and ribavirin (RBV) is the standard of care for the treatment of chronic hepatitis C virus (HCV) infection. This analysis compares the cost efficacy of treatment with pegylated interferon alfa-2b plus ribavirin (Peg-2b plus RBV) with pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Malone, Daniel C., Tran, Tram T., Poordad, F. Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438199/
https://www.ncbi.nlm.nih.gov/pubmed/16194133
http://dx.doi.org/10.18553/jmcp.2005.11.8.687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438199/
https://www.ncbi.nlm.nih.gov/pubmed/16194133
http://dx.doi.org/10.18553/jmcp.2005.11.8.687

Ejemplares similares